Author:
Mokkink Lidwine B.,Terwee Caroline B.,Patrick Donald L.,Alonso Jordi,Stratford Paul W.,Knol Dirk L.,Bouter Lex M.,de Vet Henrica C. W.
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference21 articles.
1. Committee for Medicinal Products for Human Use (CHMP). (2005). Reflection paper on the regulatory guidance for the use of health related quality of life (HRQL) measures in the evaluation of medicinal products, EMEA, London, 2005. Available at: www.emea.europa.eu/pdfs/human/ewp/13939104en.pdf . Accessed November 10, 2008.
2. US Department of Health and Human Services FDA Center for Drug Evaluation and Research, US Department of Health and Human Services FDA Center for Biologics Evaluation and Research, & US Department of Health and Human Services FDA Center for Devices and Radiological Health. (2006). Guidance for industry: patient-reported outcome measures: Use in medical product development to support labeling claims: Draft guidance. Health and Quality of Life Outcomes, 4, 79.
3. Marshall, M., Lockwood, A., Bradley, C., Adams, C., Joy, C., & Fenton, M. (2000). Unpublished rating scales: A major source of bias in randomised controlled trials of treatments for schizophrenia. British Journal of Psychiatry, 176, 249–252.
4. Lohr, K. N., Aaronson, N. K., Alonso, J., Burnam, M. A., Patrick, D. L., Perrin, E. B., et al. (1996). Evaluating quality-of-life and health status instruments: Development of scientific review criteria. Clinical Therapeutics, 18, 979–992.
5. Nunnally, J. C. (1978). Psychometric theory. New York, London: McGraw-Hill.
Cited by
2871 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献